Concepedia

Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1–2 trial

Peter D. Cole, Kathleen M. McCarten, Qinglin Pei, Menachem Spira, Monika L. Metzger, Richard A. Drachtman, Terzah M. Horton, Rizvan Bush, Susan M. Blaney, Brenda J. Weigel,

The Lancet Oncology · 2018 · 85 citations · 21 references

DOI

Concepts

References

21

Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

Bruce D. Cheson, Richard I. Fisher, Sally F. Barrington et al. · Journal of Clinical Oncology · 2014 · 5.6K citations · Full text

, , +17

Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma

Lorena Appio, Carlo Landoni, Maria La Targia et al. · Chemotherapy · 2017 · 2.3K citations · Full text

, , +17

Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma

Anas Younes, Ajay K. Gopal, Scott E. Smith et al. · Journal of Clinical Oncology · 2012 · 1.5K citations · Full text

, , +17

FcγRIIIa-158V/F Polymorphism Influences the Binding of IgG by Natural Killer Cell FcγRIIIa, Independently of the FcγRIIIa-48L/R/H Phenotype

Harry R. Koene, Marion Kleijer, Johan Algra et al. · Blood · 1997 · 782 citations · Full text

, , +12

Brentuximab Vedotin (SGN-35)

Jessica Katz, John E. Janik, Anas Younes · Clinical Cancer Research · 2011 · 363 citations

, , +16